Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma of the Ovary”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00569673
What this trial is testing

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 71
Testing effectiveness (Phase 2)Study completedNCT00459290
What this trial is testing

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 24
Early research (Phase 1)Ended earlyNCT06285097
What this trial is testing

PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

Who this might be right for
NeoplasmsNon-small-cell Lung CancerMelanoma+5 more
Pfizer 9
Not applicableStudy completedNCT01826227
What this trial is testing

Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian TubePrimary Peritoneal
Memorial Sloan Kettering Cancer Center 5
Early research (Phase 1)Ended earlyNCT03286062
What this trial is testing

VM110 in Detection of Microscopic Tumors: A Phase I Study

Who this might be right for
Ovarian CancerPancreatic Cancer
Fox Chase Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT02489903
What this trial is testing

RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)

Who this might be right for
Small Cell CarcinomaCarcinoma, Non-Small-Cell LungNeuroendocrine Tumors+1 more
EpicentRx, Inc. 139
Not applicableUnknownNCT03742856
What this trial is testing

A Multi-omics Study of Epithelial Ovarian Cancer

Who this might be right for
Epithelial Ovarian CancerTumor InvasivenessWhole Exome Sequencing+3 more
Lei Li 80
Not applicableEnrolling By InvitationNCT03544983
What this trial is testing

Genetic Education in BRCA Families

Who this might be right for
BRCA1 MutationBRCA2 Mutation
Georgetown University 240
Large-scale testing (Phase 3)Study completedNCT01506856
What this trial is testing

Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Gynecologic Oncology Trial & Investigation Consortium 655
Early research (Phase 1)Study completedNCT01266954
What this trial is testing

An Open Label Study To Investigate the Pharmacokinetics and Pharmacodynamics of Repeat Escalating Doses of the Oral AKT Inhibitor GSK2141795 by 18F FDG PET Analysis in Subjects With Ovarian Cancer

Who this might be right for
Solid Tumours
GlaxoSmithKline 36
Early research (Phase 1)Ended earlyNCT06714617
What this trial is testing

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

Who this might be right for
Breast Cancer Stage IIIHER2-positive Metastatic Breast CancerUnresectable Breast Carcinoma+11 more
SystImmune Inc. 3
Not applicableActive Not RecruitingNCT05857397
What this trial is testing

A Collaborative Trial of Niraparib to Evaluate Patients With Ovarian Cancer in the Expanded Access Program in Latin America

Who this might be right for
Ovarian Cancer
Latin American Cooperative Oncology Group 64
Not applicableUnknownNCT06320418
What this trial is testing

The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression

Who this might be right for
Ovarian Cancer
Ain Shams University 56
Not applicableStudy completedNCT04145817
What this trial is testing

Breast Cancer Risk After Diagnostic Gene Sequencing

Who this might be right for
Genetic Predisposition to Disease
Institut Curie 405
Not applicableEnded earlyNCT02441140
What this trial is testing

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian Cancer
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT03166891
What this trial is testing

Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Chipscreen Biosciences, Ltd. 25
Testing effectiveness (Phase 2)Ended earlyNCT01936974
What this trial is testing

(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma
Western Regional Medical Center 7
Not applicableStudy completedNCT00340210
What this trial is testing

Extended Follow-up of Columbia, MO Serum Bank Participants

Who this might be right for
Breast CancerEndometrial CancerOvarian Cancer
National Cancer Institute (NCI) 6,720
Not applicableStudy completedNCT03367260
What this trial is testing

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Duke University 115
Testing effectiveness (Phase 2)Study completedNCT00069160
What this trial is testing

Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer

Who this might be right for
Lung NeoplasmsOvarian NeoplasmsCervix Neoplasms+1 more
National Cancer Institute (NCI) 48
Next Page